The family of a Telford toddler with a rare genetic disorder causing hundreds of daily seizures say they have been ...

REDWOOD CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...

Following completion of the ongoing Phase 2a proof-of-pharmacology study with BMB-101, Bright Minds plans to select and ...

A 15-year-old girl with a rare chromosome disorder received a complete room renovation Friday that her family says will ...

When Skye Scott took her son to a paediatrician, she never imagined he would be diagnosed with the life-changing Duchenne ...

The international research team, which included CSIR-Centre for Cellular and Molecular Biology (CCMB), discovered that ...

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Dasatinib Tablets in strengths ...

India’s political landscape is witness to an innovative private-public partnership model. The upgrades are rapid and arrive ...

His decoding of the blueprint for life with Francis H.C. Crick made him one of the most important scientists of the 20th ...

A new deep learning framework can accurately classify four molecular subgroups of medulloblastoma and predict critical ...

Lexeo Therapeutics, Inc. surges after FDA trial alignment for LX2006 in Friedreich’s ataxia. Click for more on LXEO stock ...